[HTML][HTML] Targeting T regulatory (Treg) cells in immunotherapy-resistant cancers
P Spiliopoulou, P Kaur, T Hammett… - Cancer Drug …, 2024 - ncbi.nlm.nih.gov
Primary or secondary (ie, acquired) resistance is a common occurrence in cancer patients
and is often associated with high numbers of T regulatory (T reg) cells (CD4+ CD25+ …
and is often associated with high numbers of T regulatory (T reg) cells (CD4+ CD25+ …